Results for tag: "Nelarabine"

Nelarabine is a chemotherapy drug used to treat T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It is a purine nucleoside analog, which works by inhibiting the growth of cancer cells. Nelarabine is typically used in combination with other drugs, such as vincristine, prednisone, and daunorubicin. It is administered intravenously, usually over a period of several days. Nelarabine is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2005. It is used to treat patients who have not responded to other treatments, or who have relapsed after other treatments. It is also used to treat patients who are unable to tolerate other treatments. Nelarabine is marketed by several companies, including GlaxoSmithKline, Teva Pharmaceuticals, and Sun Pharmaceuticals. It is also available in generic form from several generic drug manufacturers. Show Less Read more